U.S. drugmaker Pfizer said on Thursday (September 3) it should know by the end of October whether a COVID-19 vaccine it is developing is successful, and will submit it for approval immediately if that is the case. Pfizer has enrolled 23,000 patients in vaccine tests as of Wednesday, its Chief Executive Albert Bourla said in an online briefing sponsored by drug industry group International Federation of Pharmaceuticals Manufacturers & Association.
Health
Coronavirus: Pfizer targets end of October for COVID-19 vaccine update
More Videos
-
Ozempic maker bringing weight-loss drug Wegovy to Canada
-
Health Matters: Newfoundland and Labrador work to hire, retain nurses through incentives
-
Toxic metals in vapes linked with major health problems in youth, study finds
-
Ozempic-makers’ weight-loss drug, Wegovy, coming soon to Canada
-
Weight-loss drug Wegovy available in Canada starting May 6
-
Health Matters: Caregiver report highlights need for help
You are viewing an Accelerated Mobile Webpage.
View Original Article